Comparison between COVID-19 and DHF co-disease with COVID-19 alone in two pediatric sibling patients

  • Suryadi Nicolaas Napoleon Tatura Department of Pediatrics, Prof. DR. R. D Kandou General Hospital/Robert Wolter Monginsidi Army Hospital/Faculty of Medicine, Universitas Sam Ratulangi, Manado, North Sulawesi
Keywords: Corona virus, Dengue, Antibody, DENV, SARS-CoV-2

Abstract

We report herein the difference between Corona virus disease-19 (COVID-19) and dengue hemorrhagic fever (DHF) co-infection compared with COVID-19 alone in two pediatric sibling patients. This case report highlights a 10-year-old boy with both COVID-19 and DHF who had less severe coagulation disorder than his sister with COVID-19 alone. In a patient with a dual infection, the presence of dengue antibodies may induce immunological protection against COVID-19. We found reports of milder symptoms in patients who had dengue prior to SARS- CoV-2 infection; however, the opposite occured when SARS-CoV-2 infection precedes dengue.

References

1. Stubbs SCB, Blacklaws BA, Yohan B, Yudhaputri FA, Hayati RF, Schwem B, et al. Assessment of a multiplex PCR and nanopore-based method for dengue virus sequencing in Indonesia. Virol J. 2020;17:24. DOI: https://doi.org/10.1186/s12985-020- 1294-6
2. Nasomsong W, Luvira V, Phiboonbanakit D. Case report: dengue and COVID-19
coinfection in Thailand. Am J Trop Med Hyg. 2020;104:487-9. DOI: https://doi.org/10.4269/ajtmh.20-1340
3. Verduyn M, Allou N, Gazaille V, Andre M, Desroche T, Jaffar MC, et al. Co-infection of dengue and COVID-19: a case report. PloS Negl Trop Dis. 2020;14:e0008476. DOI: https://doi.org/10.1371/journal.pntd.0008476
4. Tatura SNN, Denis D, Santoso MS, Hayati RF, Kepel BJ, Yohan B, et al. Outbreak of severe dengue associated with DENV-3 in the city of Manado, North Sulawesi, Indonesia. Int J Infect Dis. 2021;106:185-96. DOI: https://doi.org/10.1016/j.ijid.2021.03.065
5. Bicudo N, Bicudo E, Costa JD, Castro J, Barra GB. Co-infection of SARS-CoV-2 and dengue virus: a clinical challenge. Braz J Infect Dis. 2020;24:452-4. DOI: https://doi.org/10.1016/j.bjid.2020.07.008
6. Nicolelis MA, Raimundo RL, Peixoto PS, de Andreazzi CS. How super-spreader cities, highways, hospital bed availability, and dengue fever influenced the COVID-19 https://doi.org/epidemic in Brazil. Sci Rep. 2021;11:13001. DOI: https://doi.org/10.1016/j.bjid.2020.07.008
7. Gupta B, Nehara H, Parmar S, Meena S, Gajraj S, Gupta J. Acute abdomen presentation in dengue fever during recent outbreak. J Acute Dis. 2017;6:198-204. DOI: https://doi.org/10.4103/2221-6189.219612
8. Weerakoon KGAD, Chandrasekaramb S, Jayabahu JPSNK, Gunasena S, Kularatne SAM. Acute abdominal pain in dengue haemorrhagic fever: a study in Sri Lanka, 2009. WHO Dengue Bull. 2009;33:70-4.

9. Mayor S. Covid-19: UK studies find gastrointestinal symptoms are common in children. BMJ. 2020;370:m3484. DOI: https://doi.org/10.1136/bmj.m3484.
10. Henry BM, de Oliveira MHS, Benoit J, Lippi G. Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis. Intern Emerg Med. 2020;15:857-9.
11. Vinayagam S, Sattu K. SARS-CoV-2 and coagulation disorders in different organs. Life Sci. 2020;260:118431. DOI: https://doi.org/10.1007/s11739-020-02329-9
12. Suresh VCS, Mukherjee S, Harne PS, Subedi A, Ganapathy MK, Patthipati VS, et al . Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19. BMJ Open Gastroenterol. 2020;7:e000417. DOI: https://doi.org/10.1136/bmjgast-2020-000417
13. Violi F, Pastori D, Cangemi R, Pignatelli P, Loffredo L. Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge. Thromb Haemost. 2020;120:949-56. DOI: https://doi.org/10.1055/s-0040-1710317
14. Yan G, Lee CK, Lam LTM, Yan B, Chua YX, Lim AYN, et al. Covert COVID-19 and false- positive dengue serology in Singapore. Lancet Infect Dis. 2020;20:536. DOI: 10.1016/S1473-3099(20)30158-4. Epub 2020 Mar 4. PMID: 32145189; PMCID: PMC7128937.
15. Nath H, Mallick A, Roy S, Sukla S, Basu K, De A, et al. Dengue antibodies can cross-react with SARS-CoV-2 and vice versa-antibody detection kits can give false-positive results for both viruses in regions where both COVID-19 and Dengue co-exist. J Med Microbiol. 2021;70:001369. DOI: https://doi.org/10.1099/jmm.0.001369
16. Silvestre OM, Costa LR, Lopes BVR, Barbosa MR, Botelho KKP, Albuquerque KLC, et al. Previous dengue infection and mortality in COVID-19. Clin Infect Dis. 2021;73: e1219– e1221. DOI: https://doi.org/10.1093/cid/ciaa1895.
17. Ulrich H, Pillat MM, Tárnok A. Dengue fever, COVID-19 (SARS-CoV-2), and antibody- dependent enhancement (ADE): a perspective. Cytometry A. 2020;97:662-7. DOI: https://doi.org/10.1002/cyto.a.24047
18. Liu L, Wei Q, Lin Q, Fang J, Wang H, Kwok H, et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 2019;4:e123158. DOI: https://doi.org/10.1172/jci.insight.123158

19. Tan C, Li S, Liang Y, Chen M, Liu J. SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patients. Braz J Infect Dis. 2020;24:565-9. DOI: https://doi.org/10.1016/j.bjid.2020.08.010
20. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181:2-9. DOI: https://doi.org/10.1086/315215
21. Ricke DO. Two different antibody-dependent enhancement (ADE) risks for SARS-CoV-2 antibodies. Front Immunol. 2021;12:640093. DOI: https://doi.org/10.3389/fimmu.2021.640093
22. Ajmeriya S, Kumar A, Karmakar S, Rana S, Singh H. Neutralizing antibodies and antibody-dependent enhancement in COVID-19: a perspective. J Indian Inst Sci. 2022;102(2): 671-687. DOI: https://doi.org/10.1007/s41745-021-00268-8
23. Alam A, Sudarwati S, Hakim DDL, Mahdiani S. Case report: severe COVID-19 and dengue in an Indonesian infant. Am J Trop Med Hyg. 2021;104:1456-60. DOI: https://doi.org/10.4269/ajtmh.20-1244
24. Tiwari L, Shekhar S, Bansal A, Kumar P. COVID-19 with dengue shock syndrome in a child: coinfection or cross-reactivity? BMJ Case Rep. 2020;13:e239315. DOI: 10.1136/bcr- 2020-239315.
25. Kazi MA, Ghosh S, Roychowdhury S, Giri PP, Sarkar M. A case study of dual infection of dengue and COVID-19: presenting as multiorgan dysfunction in an infant. J Trop Pediatr. 2020;67:fmaa080. DOI: https://doi.org/10.1093/tropej/fmaa080.
26. Somasetia DH, Malahayati TT, Andriyani FM, Setiabudi D, Nataprawira HM. A fatal course of multiple inflammatory syndrome in children coinfection with dengue. A case report from Indonesia. IDCases. 2020;22:e01002. DOI: https://doi.org/10.1016/j.idcr.2020.e01002
Published
2024-05-28
How to Cite
1.
Tatura S. Comparison between COVID-19 and DHF co-disease with COVID-19 alone in two pediatric sibling patients. PI [Internet]. 28May2024 [cited 15Jul.2024];64(3):281-. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/3337
Section
Case Report
Received 2023-01-11
Accepted 2024-05-28
Published 2024-05-28